Mutations in BRCA1 and BRCA2 genes are major contributors to ovarian cancer risk, as these genes play crucial roles in DNA repair through the homologous recombination pathway, ensuring cellular genetic stability. The gene discussed is BRCA1; the disease is ovarian carcinoma.